<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04961749</url>
  </required_header>
  <id_info>
    <org_study_id>1745950-2</org_study_id>
    <nct_id>NCT04961749</nct_id>
  </id_info>
  <brief_title>Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy</brief_title>
  <acronym>CP_WBVT</acronym>
  <official_title>Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas, El Paso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the retention effects of a four-week whole-body vibration training&#xD;
      intervention in children with Cerebral Palsy. The primary outcomes for this study are gait&#xD;
      function, including Timed Up and Go and the two-minute walk test. Secondary outcomes of this&#xD;
      study include lower extremity gait function, coordination, and gait variability. For this&#xD;
      study, a total of 10 children with Cerebral Palsy (CP) will be recruited with 5 being&#xD;
      randomly placed into an experimental group and 5 being randomly placed into a control group.&#xD;
      Each participant, regardless of group, will complete pre-, post-, and retention testing, with&#xD;
      a four-week whole-body vibration training intervention between the pre- and post-testing. The&#xD;
      four-week whole-body vibration training will include three visits per week, with the&#xD;
      experimental group receiving a vibration stimulus while standing on a vibration platform.&#xD;
      Vibration sessions will consist of three-minutes of vibration, followed by three minutes&#xD;
      rest, completing this cycle three separate times. The control group will follow a similar&#xD;
      pattern, but rather than experiencing vibration, they will hear a sound of the vibration&#xD;
      platform through a speaker. Once the four-week training session is finished, participants&#xD;
      will return after a three-month retention period to determine whether ambulation function was&#xD;
      retained.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2021</start_date>
  <completion_date type="Anticipated">June 16, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 16, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Timed up and go test</measure>
    <time_frame>16 weeks</time_frame>
    <description>Amount of time to quickly and safely complete the test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Two-minute walk test</measure>
    <time_frame>16 weeks</time_frame>
    <description>Distance covered while walking for two minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lower extremity gait function</measure>
    <time_frame>16 weeks</time_frame>
    <description>Three-dimensional motion capture will be used to track lower extremity segment movement patterns. All measurements will have units of degrees</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>CP</condition>
  <condition>Gait Disorders, Neurologic</condition>
  <condition>Locomotion Disorder, Neurologic</condition>
  <arm_group>
    <arm_group_label>Vibration group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive vibration stimulation while standing on a side-alternating vibration platform. Vibration sessions will occur three times per week over four-weeks. Each session will include three-minutes of vibration followed by three-minutes rest, completing this sequence three times per session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive vibration, but will rather hear a recording of the vibration, while still standing on the vibration platform. Still, this group will receive this training three times per week over four-weeks with a similar three-minute rotation as the vibration group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole body vibration training</intervention_name>
    <description>Whole-body vibration training applies a vibration stimulus to an individual as they are standing on a side-alternating platform. The vibration creates small muscle contractions in the lower extremity musculature which has been shown to improve function and ambulatory function.</description>
    <arm_group_label>Vibration group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Cerebral Palsy&#xD;
&#xD;
          -  Ability to walk independently&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Musculoskeletal injuries or conditions (other than Cerebral Palsy) which alter their&#xD;
             independent walking ability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey D Eggleston, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas at El Paso</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeffrey D Eggleston, PhD</last_name>
    <phone>915-747-6012</phone>
    <email>jdeggleston@utep.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas at El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79968</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey D Eggleston, PhD</last_name>
      <phone>915-747-6012</phone>
      <email>jdeggleston@utep.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2021</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas, El Paso</investigator_affiliation>
    <investigator_full_name>Jeffrey Eggleston</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Cerebral Palsy</keyword>
  <keyword>Locomotion</keyword>
  <keyword>Pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 17, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT04961749/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

